loadpatents
name:-0.083022117614746
name:-0.057953119277954
name:-0.048254013061523
DING; Charles Z. Patent Filings

DING; Charles Z.

Patent Applications and Registrations

Patent applications and USPTO patent grants for DING; Charles Z..The latest application filed is for "preparation method for oxazepine compound".

Company Profile
41.50.75
  • DING; Charles Z. - Shanghai CN
  • Ding; Charles Z. - Nanjing Jiangsu
  • DING; Charles Z - Shanghai CN
  • Ding; Charles Z. - San Mateo CA
  • Ding; Charles Z. - Palo Alto CA US
  • Ding; Charles Z. - Piano TX
  • Ding; Charles Z. - Foster City CA
  • Ding; Charles Z. - Plano TX
  • Ding; Charles Z. - Dallas TX
  • Ding; Charles Z. - Plainsboro NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Preparation Method for Oxazepine Compound
App 20220306648 - HU; Yanbin ;   et al.
2022-09-29
Pyridone-pyrimidine derivative acting as KRASG12C mutein inhibitor
Grant 11,453,667 - Cai , et al. September 27, 2
2022-09-27
Pyrimidine Compound Acting On Egfr And Erbb2
App 20220289714 - DING; Charles Z. ;   et al.
2022-09-15
Macrocyclic Derivatives As Factor Xia Inhibitors
App 20220281868 - CAI; Yaxian ;   et al.
2022-09-08
Crystal Form Of C-met/axl Inhibitor
App 20220235029 - LI; Gang ;   et al.
2022-07-28
Tetracyclic Compounds As Cdc7 Inhibitors
App 20220235068 - Li; Gang ;   et al.
2022-07-28
Antibacterial Aminoglycoside Derivatives
App 20220227802 - TANG; Dongdong ;   et al.
2022-07-21
Aryl-phosphorus-oxygen compound as EGFR kinase inhibitor
Grant 11,390,625 - Wu , et al. July 19, 2
2022-07-19
Macrocyclic Derivatives Acting As Xia Factor Inhibitor
App 20220204508 - Cai; Yaxian ;   et al.
2022-06-30
Crystal Form Of Egfr Inhibitor And Preparation Method Thereof
App 20220194959 - LIU; Xile ;   et al.
2022-06-23
SMAC mimetics used as IAP inhibitors and use thereof
Grant 11,358,950 - Liu , et al. June 14, 2
2022-06-14
Crystallization Of Smac Mimic Used As Iap Inhibitor And Preparation Method Thereof
App 20220177453 - Liu; Yingchun ;   et al.
2022-06-09
Combination Of Iap Inhibitor And Immune Checkpoint Inhibitor
App 20220175917 - LIU; Yingchun ;   et al.
2022-06-09
Indolo Heptamyl Oxime Analogue As Parp Inhibitor
App 20220144850 - Hu; Yanbin ;   et al.
2022-05-12
Salt Of Egfr Inhibitor, Crystal Form, And Preparation Method Therefor
App 20220119431 - WU; Lingyun ;   et al.
2022-04-21
5-(4-pyridyloxy)pyrazole Compounds Serving As Tgf- R1 Kinase Inhibitor
App 20220098171 - FU; Xiangyu ;   et al.
2022-03-31
Application Of Monocyclic -lactam Compound In Pharmacy
App 20220062244 - WEI; Xiawei ;   et al.
2022-03-03
Salt serving as AKT inhibitor and crystal thereof
Grant 11,261,196 - Li , et al. March 1, 2
2022-03-01
Estrogen Receptor Antagonist
App 20220033376 - DUAN; Shuwen ;   et al.
2022-02-03
Crystal form and salt form of TGF-.beta.RI inhibitor and preparation method therefor
Grant 11,236,112 - Wu , et al. February 1, 2
2022-02-01
Crystal Form of Hepatitis B Surface Antigen Inhibitor
App 20220017536 - HU; Yanbin ;   et al.
2022-01-20
Salt Form of Estrogen Receptor Downregulator, Crystalline Form Thereof, and Preparation Method Therefor
App 20220017463 - HE; Huijun ;   et al.
2022-01-20
3,9-diazaspiro[5,5]undecane Compound As Flt3 And Axl Inhibitors
App 20210395252 - FU; Xiangyu ;   et al.
2021-12-23
Tlr8 Agonist
App 20210371414 - Cai; Zhe ;   et al.
2021-12-02
Uracil Compound As C-met/axl Inhibitor
App 20210371395 - LI; Jinping ;   et al.
2021-12-02
Smac Mimetics Used As Iap Inhibitors And Use Thereof
App 20210371400 - Liu; Yingchun ;   et al.
2021-12-02
Pyridone-pyrimidine Derivative Acting As Krasg12c Mutein Inhibitor
App 20210371411 - CAI; Yaxian ;   et al.
2021-12-02
Crystal form of .beta.-lactamase inhibitor and preparation method therefor
Grant 11,180,501 - Li , et al. November 23, 2
2021-11-23
Tlr8 Agonist
App 20210340141 - SUN; Fei ;   et al.
2021-11-04
Crystal Form Of C-met Inhibitor And Salt Form Thereof And Preparation Method Therefor
App 20210238163 - XU; Xiongbin ;   et al.
2021-08-05
Quinazoline compound for EGFR inhibition
Grant 11,040,984 - Liu , et al. June 22, 2
2021-06-22
Crystal form of estrogen receptor inhibitor and preparation method therefor
Grant 11,034,653 - He , et al. June 15, 2
2021-06-15
Pyridone-Pyrimidine Derivative Acting As KRASG12C Mutein Inhibitor
App 20210147418 - CAI; Yaxian ;   et al.
2021-05-20
Hepatitis B virus surface antigen inhibitor
Grant 11,008,331 - Sun , et al. May 18, 2
2021-05-18
Monocyclic B-lactam Compound For Treating Bacterial Infection
App 20210115035 - GU; Lianghu ;   et al.
2021-04-22
Salt Serving As Akt Inhibitor And Crystal Thereof
App 20210087205 - LI; Gang ;   et al.
2021-03-25
Crystal Form And Salt Form Of Tgf-bri Inhibitor And Preparation Method Therefor
App 20210079021 - WU; Lifang ;   et al.
2021-03-18
Salt type and crystal type of 4h-pyrazolo [1, 5-alpha] benzimidazole compound and preparation method and intermediate thereof
Grant 10,941,150 - Wang , et al. March 9, 2
2021-03-09
Crystal Form Of -lactamase Inhibitor And Preparation Method Therefor
App 20200385385 - LI; Cheng ;   et al.
2020-12-10
Anti-hbvtetrahydroisoxazolo[4,3-c]pyridine Compounds
App 20200377517 - WU; Lifang ;   et al.
2020-12-03
M-dihydroxybenzene derivative crystal and salt, and manufacturing method thereof
Grant 10,851,071 - Yan , et al. December 1, 2
2020-12-01
Indolo substituted piperidine compound as estrogen receptor down-regulator
Grant 10,774,081 - Lu , et al. Sept
2020-09-15
.beta.-lactamase inhibitors
Grant 10,738,051 - Hu , et al. A
2020-08-11
Crystal Form Of Estrogen Receptor Inhibitor And Preparation Method Therefor
App 20200247748 - Kind Code
2020-08-06
Aryl-Phosphorus-Oxygen Compound As EGFR Kinase Inhibitor
App 20200207768 - WU; Lingyun ;   et al.
2020-07-02
Hepatitis B Virus Surface Antigen Inhibitor
App 20200197409 - DING; Charles Z. ;   et al.
2020-06-25
Quinazoline Compound For Egfr Inhibition
App 20200190107 - LIU; Xile ;   et al.
2020-06-18
1,6-naphthyridine derivatives as CDK4/6 inhibitor
Grant 10,676,474 - Xu , et al.
2020-06-09
Dihydropyrazole azepine compound serving as Akt inhibitor
Grant 10,654,868 - Lu , et al.
2020-05-19
Crystal form, salt type of substituted 2-hydro-pyrazole derivative and preparation method therefor
Grant 10,626,107 - Ding , et al.
2020-04-21
JAK inhibitor
Grant 10,617,690 - Wu , et al.
2020-04-14
Hepatitis B Virus Surface Antigen Inhibitor
App 20200039995 - SUN; Fei ;   et al.
2020-02-06
Benzotriazole-derived .alpha. and .beta.-unsaturated amide compound used as TGF-.beta. RI inhibitor
Grant 10,548,883 - Sun , et al. Fe
2020-02-04
Novel Beta-lactamase Inhibitors
App 20200010467 - HU; Boyu ;   et al.
2020-01-09
Substituted-indole-compounds as estrogen receptor down-regulators
Grant 10,519,143 - Lu , et al. Dec
2019-12-31
Benzimidazole-linked indole compound acting as novel divalent IAP antagonist
Grant 10,508,103 - Sun , et al. Dec
2019-12-17
Salt Type And Crystal Type Of 4h-Pyrazolo [1, 5-Alpha] Benzimidazole Compound And Preparation Method And Intermediate Thereof
App 20190375756 - WANG; Xuehai ;   et al.
2019-12-12
Pyridone compound as c-met inhibitor
Grant 10,501,443 - Xu , et al. Dec
2019-12-10
Fused-ring or tricyclic aryl pyrimidine compound used as kinase inhibitor
Grant 10,494,373 - Ding , et al. De
2019-12-03
Indolo Substituted Piperidine Compound As Estrogen Receptor Degrading Agent
App 20190337938 - LU; Jianyu ;   et al.
2019-11-07
Cdk4/6 Inhibitor
App 20190315745 - XU; Zhaobing ;   et al.
2019-10-17
Salt type and crystal type of 4H-pyrazolo [1, 5-alpha] benzimidazole compound and preparation method and intermediate thereof
Grant 10,428,073 - Wang , et al. October 1, 2
2019-10-01
M-dihydroxybenzene Derivative Crystal And Salt, And Manufacturing Method Thereof
App 20190284146 - YAN; Xiaobing ;   et al.
2019-09-19
Crystal And Salt Of Nitroimidazole, And Manufacturing Method Thereof
App 20190276475 - LUO; Wei ;   et al.
2019-09-12
Pyridone Compound As C-met Inhibitor
App 20190248763 - XU; Xiongbin ;   et al.
2019-08-15
Dihydropyrazole Azepine Compound Serving As Akt Inhibitor
App 20190233434 - LU; Lun ;   et al.
2019-08-01
Crystal Form, Salt Type Of Substituted 2-hydro-pyrazole Derivative And Preparation Method Therefor
App 20190194168 - Ding; Charles Z. ;   et al.
2019-06-27
Benzotriazole-derived Alpha And Beta-unsaturated Amide Compound Used As Tgf-beta Ri Inhibitor
App 20190151299 - SUN; Fei ;   et al.
2019-05-23
Benzimidazole-linked Indole Compound Acting As Novel Divalent Iap Antagonist
App 20190135794 - SUN; Fei ;   et al.
2019-05-09
Substituted-indole-compounds As Estrogen Receptor Down-regulators
App 20190106414 - LU; Jianyu ;   et al.
2019-04-11
Anti-pulmonary tuberculosis nitroimidazole derivative
Grant 10,227,362 - Luo , et al.
2019-03-12
Fused-ring Or Tricyclic Aryl Pyrimidine Compound Used As Kinase Inhibitor
App 20180354953 - DING; Charles Z. ;   et al.
2018-12-13
Fused-ring or tricyclic aryl pyrimidine compound used as kinase inhibitor
Grant 10,093,656 - Ding , et al. October 9, 2
2018-10-09
Salt Type And Crystal Type Of 4h-pyrazolo [1, 5-alpha] Benzimidazole Compound And Preparation Method And Intermediate Thereof
App 20180258093 - WANG; Xuehai ;   et al.
2018-09-13
Resorcinol derivative as HSP90 inhibitor
Grant 10,035,792 - Chen , et al. July 31, 2
2018-07-31
Anti-pulmonary Tuberculosis Nitroimidazole Derivative
App 20180162878 - LUO; Wei ;   et al.
2018-06-14
Toll-like Receptor-7 Agonist
App 20180148452 - DING; Charles Z. ;   et al.
2018-05-31
Substituted 2-hydrogen-pyrazole derivative serving as anticancer drug
Grant 9,969,719 - Ding , et al. May 15, 2
2018-05-15
Substituted 2-hydrogen-pyrazole Derivative Serving As Anticancer Drug
App 20180072707 - Ding; Charles Z. ;   et al.
2018-03-15
Fused-Ring Or Tricyclic Aryl Pyrimidine Compound Used As Kinase Inhibitor
App 20180072704 - DING; Charles Z. ;   et al.
2018-03-15
Resorcinol Derivative As HSP90 Inhibitor
App 20180009794 - CHEN; Shuhui ;   et al.
2018-01-11
Jak Inhibitor
App 20170360794 - WU; Hao ;   et al.
2017-12-21
Piperidine-dione Derivatives
App 20170001990 - CHEN; Jinhua ;   et al.
2017-01-05
Boron-containing Small Molecules As Anti-inflammatory Agents
App 20140011768 - Akama; Tsutomu ;   et al.
2014-01-09
Boron-containing small molecules as anti-inflammatory agents
Grant 8,461,135 - Akama , et al. June 11, 2
2013-06-11
Boron-containing Small Molecules As Anti-inflammatory Agents
App 20120214765 - Akama; Tsutomu ;   et al.
2012-08-23
Boron-containing small molecules as anti-inflammatory agents
Grant 8,039,450 - Akama , et al. October 18, 2
2011-10-18
Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
Grant 7,951,793 - Cheng , et al. May 31, 2
2011-05-31
Quinolone carboxylic acid-substituted rifamycin derivatives
Grant 7,884,099 - Ding , et al. February 8, 2
2011-02-08
Boron-containing Small Molecules
App 20100256092 - Xia; Yi ;   et al.
2010-10-07
Nitroheteroaryl-containing rifamycin derivatives
Grant 7,678,791 - Ding , et al. March 16, 2
2010-03-16
Bicyclic nitroimidazole-substituted phenyl oxazolidinones
Grant 7,666,864 - Ding , et al. February 23, 2
2010-02-23
Boron-Containing Small Molecules as Anti-Inflammatory Agents
App 20090291917 - Akama; Tsutomu ;   et al.
2009-11-26
Bicyclic Nitroimidazole-substituted Phenyl Oxazolidinones
App 20090281088 - Ding; Charles Z. ;   et al.
2009-11-12
Quinolone Carboxylic Acid-substituted Rifamycin Derivatives
App 20090143373 - Ding; Charles Z. ;   et al.
2009-06-04
Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
Grant 7,507,757 - Cheng , et al. March 24, 2
2009-03-24
Nitroheteroaryl-containing rifamycin derivatives
App 20080139577 - Ding; Charles Z. ;   et al.
2008-06-12
Substituted Heterocyclic Derivatives Useful As Antidiabetic And Antiobesity Agents And Method
App 20070287713 - Cheng; Peter T. W. ;   et al.
2007-12-13
Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
Grant 7,279,485 - Cheng , et al. October 9, 2
2007-10-09
Rifamycin C-11 oxime derivatives effective against drug-resistant microbes
Grant 7,256,187 - Li , et al. August 14, 2
2007-08-14
Rifamycin derivatives effective against drug-resistant microbes
Grant 7,247,634 - Ma , et al. July 24, 2
2007-07-24
Rifamycin imino derivatives effective against drug-resistant microbes
Grant 7,238,694 - Ding , et al. July 3, 2
2007-07-03
Rifamycin derivatives
Grant 7,229,996 - Ma , et al. June 12, 2
2007-06-12
(R/S) rifamycin derivatives, their preparations and pharmaceutical compositions
Grant 7,226,931 - Ding , et al. June 5, 2
2007-06-05
Rifamycin derivatives
App 20060019985 - Ma; Zhenkun ;   et al.
2006-01-26
(R/S) rifamycin derivatives, their preparations and pharmaceutical compositions
App 20060019986 - Ding; Charles Z. ;   et al.
2006-01-26
Rifamycin derivatives effective against drug-resistant microbes
App 20050261262 - Ma, Zhenkun ;   et al.
2005-11-24
Rifamycin imino derivatives effective against drug-resistant microbes
App 20050209210 - Ding, Charles Z. ;   et al.
2005-09-22
Rifamycin C-11 oxime derivatives effective against drug-resistant microbes
App 20050203076 - Li, Jing ;   et al.
2005-09-15
(1-phenyl-2-heteoaryl)ethyl-guanidine compounds as inhibitors of mitochondrial F1F0 ATP hydrolase
Grant 6,916,813 - Atwal , et al. July 12, 2
2005-07-12
Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
App 20050119312 - Cheng, Peter T.W. ;   et al.
2005-06-02
Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
Grant 6,875,782 - Cheng , et al. April 5, 2
2005-04-05
Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
App 20040063762 - Cheng, Peter T. W. ;   et al.
2004-04-01
Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
App 20040063700 - Cheng, Peter T.W. ;   et al.
2004-04-01
(1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial F1F0 ATP hydrolase
App 20040039033 - Atwal, Karnail S. ;   et al.
2004-02-26
Benzodiazepine inhibitors of mitochondial F1F0 ATP hydrolase and methods of inhibiting F1F0 ATP hydrolase
App 20040009972 - Ding, Charles Z. ;   et al.
2004-01-15
Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase
Grant 6,624,157 - Ding September 23, 2
2003-09-23
Inhibitors of farnesyl protein transferase
Grant 6,602,883 - Bhide , et al. August 5, 2
2003-08-05
Inhibitors of farnesyl protein transferase
Grant 6,455,523 - Ding , et al. September 24, 2
2002-09-24
Inhibitors of farnesyl protein transferase
Grant 6,387,926 - Bhide , et al. May 14, 2
2002-05-14
Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase
App 20010039273 - Ding, Charles Z.
2001-11-08
Inhibitors of farnesyl protein transferase
Grant 6,011,029 - Ding , et al. January 4, 2
2000-01-04
Sulfonamido substituted benzopyran derivatives
Grant 5,869,478 - Ding , et al. February 9, 1
1999-02-09
Aryl urea and related compounds
Grant 5,547,966 - Atwal , et al. August 20, 1
1996-08-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed